Watson Pharmaceuticals, Inc. (WPI) and Gedeon Richter Ltd. Announce Exclusive License Agreement with PregLem SA for Esmya(TM); Watson to pay PregLem $17M
12/16/2010 6:39:38 AM
More...
|
Ipsen Sells its Shares in PregLem SA to Gedeon Richter Ltd.
10/11/2010 12:21:14 PM
More...
|
Richter International, Inc. Buys Swiss PregLem SA for up to $461 Million
10/8/2010 7:53:52 AM
More...
|
PregLem SA Announces In-Licensing Deal With Merck Serono For Post-Operative Adhesions & Endometriosis
8/11/2010 8:26:29 AM
More...
|
PregLem SA Said to Hire Credit Suisse for Possible Initial Public Offering
7/9/2010 8:47:46 AM
More...
|
PregLem SA Announces Positive Phase III Results for Esmya(TM)
6/3/2010 6:47:26 AM
More...
|
PregLem SA Announces Positive Phase 3 Results For Esmya(TM) as an Effective Treatment For Uterine Fibroids; PEARL II Study Meets Both Primary Efficacy and Safety Endpoints
5/19/2010 9:03:50 AM
More...
|
PregLem SA Presenting At JP Morgan Healthcare Conference
1/12/2010 8:13:15 AM
More...
|
PregLem SA Announces The Appointment Of Dr Suhail Nurbhai As Chief Medical Officer
6/2/2009 3:32:42 PM
More...
|
Fritz Kunz Joins PregLem SA's Board of Directors
9/9/2008 2:26:13 PM
More...
|
|